Bactiguard
OverviewSuggest Edit
Bactiguard, a medtech company, develops and provides infection prevention solutions. Its products include bactiguard infection protection (BIP) foley catheter, an indwelling urinary catheter used for drainage and irrigation of the bladder, or for the collection and measurement of patient urine; BIP central venous catheters that administer medication and intravenous solutions, measures pressure, and collects blood samples; and BIP endotracheal tube for use in airway management by oral or nasal intubation of the trachea.
| Type | Public | |
| Founded | 2005 | |
| HQ | Botkyrka, SE | Map |
| Website | bactiguard.se |
Latest Updates
| Employees (est.) (Dec 2021) | 210 | (+17%) |
| Share Price (Nov 2021) | KR171 |
Bactiguard Office Locations
Bactiguard has an office in Botkyrka
Botkyrka, SE (HQ)
Tullinge
Bactiguard Financials and Metrics
Bactiguard Revenue
Market capitalization (10-Nov-2021) | 5.7b |
Closing stock price (10-Nov-2021) | 171.0 |
Bactiguard's current market capitalization is kr5.7 b.
Bactiguard Environment, Social & Governance (ESG) Ratings
Bactiguard Online and Social Media Presence
618 Twitter followers
Bactiguard has 618 Twitter Followers. The number of followers has increased 0.4% month over month and increased 1.3% quarter over quarter
Bactiguard's Trends
Twitter Engagement Stats for @Bactiguard
3.1k
Tweets
888
Following
618
Followers
4
Tweets last 30 days
1.8
Avg. likes per Tweet
75%
Tweets with engagement
Bactiguard News and Updates
October 28, 2021
Interim report for Q3 2021 : Bactiguard Holding AB (publ)
STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Capital injection initiates a new phase of accelerated expansion Third quarter (July-September 2021) Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. EBITDA amounted to SEK 1....
August 31, 2021
Bactiguard recruits Chief Licensing Officer to accelerate growth
STOCKHOLM, Aug. 31, 2021 /PRNewswire/ -- Carl Johan Fredin, with many years of international experience from leading companies and positions in pharmaceuticals, MedTech and healthcare, has been recruited to a new role as Chief Licensing Officer. Carl Johan, whose most recent position was...
July 01, 2021
Bactiguard receives payment from Zimmer Biomet
STOCKHOLM, July 1, 2021 /PRNewswire/ -- Following successful European regulatory clearance and market launch of Bactiguard-coated Zimmer Biomet trauma implants (ZNN Bactiguard), the initial USD 1 million milestone payment has been released. "I am excited about our partnership with Zimmer...
January 12, 2021
Bactiguard launches Hydrocyn aqua in Greece
Bactiguard continues the launch of the Hydrocyn® aqua (Hydrocyn) product range in Europe by entering a new partnership with Lifecyn S.A. (Lifecyn) in Greece. The collaboration is based on an exclusive distribution agreement for Bactiguard’s Hydrocyn® aqua range, including products for advanced disin…
May 13, 2020
Bactiguard appoints Gabriella Bjorknert Caracciolo as new CFO
Bactiguard Holding AB (publ) has appointed Gabriella Björknert Caracciolo, currently Head of Strategy, Development and Governance within Transaction Banking, Nordea as new CFO and Executive Vice President. She succeeds Cecilia Edström, who in February was appointed CEO of the company. Gabriella Bj…
February 05, 2020
Year-end Report 2019 Bactiguard Holding AB
STOCKHOLM, Feb. 5, 2020 /PRNewswire/ -- A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show...
Bactiguard Blogs
January 21, 2022
The silent pandemic of antimicrobial resistance is louder than ever
Antimicrobial resistance already causes millions of deaths according to the most comprehensive study on the burden of AMR so far, published in The Lancet. It shows that almost 1,3 million deaths were directly attributable to bacterial AMR in 2019 and almost 5 million deaths associated with AMR. This…
January 10, 2022
Clinical study on Bactiguard’s endotracheal tube now published – shows significant reduction of ventilator-associated pneumonia
The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube. It was presented for the first time at the European Society of Inte…
December 23, 2021
Exciting future for Bactiguard with CEO Anders Göransson
Three months have passed since Anders Göransson became CEO of Bactiguard and he speaks with excitement about the future of the company and the growth journey that lays ahead. “Hearing the great feedback from our partners and patients makes me realise that I made the right choice to join Bactiguard”,…
December 13, 2021
Gabriella Björknert Caracciolo has today announced that she will leave the role as CFO and deputy CEO for Bactiguard Holding AB (publ)
“Gabriella is a key person in the company and she has made an impactful contribution to establishing the platform for our continued expansion. While I regret that she has chosen to leave Bactiguard I respect her decision to return to the financial sector. I want to thank her for her significant cont…
November 18, 2021
Stop antimicrobial resistance through awareness
What if pneumonia or urinary tract infections could not be treated? Antimicrobial resistance could result in common infections becoming difficult to treat in the future and in worst case, even be fatal. The WHO initiative, World Antimicrobial Awareness Week, which starts today, aims at spreading awa…
November 17, 2021
Bactiguard ranks higher on Allbright’s list of equality
This year Bactiguard has excelled the previous year’s equality ranking from number 57 to 19 among Sweden’s listed companies. Each year Allbright ranks the companies listed on the Stockholm stock market, based on equality, with the most equal companies ranked on the green list. Bactiguard works activ…
Bactiguard Frequently Asked Questions
When was Bactiguard founded?
Bactiguard was founded in 2005.
How many employees does Bactiguard have?
Bactiguard has 210 employees.
Who are Bactiguard competitors?
Competitors of Bactiguard include Enzymatica, Inspire Living and Enzyre.
Where is Bactiguard headquarters?
Bactiguard headquarters is located at Tullinge, Botkyrka.
Where are Bactiguard offices?
Bactiguard has an office in Botkyrka.
How many offices does Bactiguard have?
Bactiguard has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies